Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Blood test

IL-6 Blood Test: Results, Range, and Long COVID Limits

A value of 3 pg/mL can be high on one IL-6 report and normal on another. Start with the method, sample, handling, and range printed by your laboratory. Then ask what the test was meant to answer.

What it measures One immune messenger in serum or plasma Current lab limits Under 1.8 to under 7 pg/mL, by method What it cannot prove The cause of persistent fatigue or cognitive symptoms Collection and treatment details Handling, exercise, illness, and immune therapy
01

What an IL-6 blood test can show

A value of 3 pg/mL can be high on one report and normal on another. The methods, samples, and handling are different. Start with the reason for the test and the range on your report. Then check what was happening near the blood draw and whether the result changes care.

What it measures

It measures one immune message protein

IL-6 helps the body respond to infection, control fever, manage energy, and send messages from working muscles. Many events can change the level.

Method

The test method sets the range

Serum immunoassays, bead assays, and plasma Luminex tests use different samples, handling, and comparison groups.

Possible causes

Many things can raise IL-6

Infection, injury, inflammatory disease, cancer, treatment, and exercise can raise it. The rest of the health check must find the cause.

Limit

Blood is not a brain sample

A blood result can't show where IL-6 came from or whether it caused memory or attention problems.

IL-6 is not a stand-alone brain-fog test

Studies of IL-6, Long COVID, and thinking problems do not agree. CDC says no blood marker can diagnose Long COVID. IL-6 alone cannot confirm or dismiss the illness.

Save this test

Save the method with the number

My Fog keeps the method, sample, handling, same-day events, medicines, other tests, and next step with the number.

Repeat only when the result could change a decision, using similar conditions and the same method.

02

How age, sex, pregnancy, and treatment change the question

There is no single IL-6 target for every age or sex. Use the laboratory's method and range. Illness, treatment, and the reason for testing also matter.

Babies and young children

Use a range approved by the child's laboratory, not an adult range. Specialists may add cytokine tests to selected workups for high fever and severe immune illness.

Children and teenagers

Infection or inflammatory illness can raise IL-6, but the number does not name the disease. A normal result does not erase severe fatigue, thinking problems, or a crash after activity.

Adult women and men

Most current laboratories do not give separate limits for men and women. One 2026 Luminex laboratory uses 0 to 7.14 pg/mL for both. Use the range on the report.

Pregnancy and breastfeeding

There is no general IL-6 target for pregnancy or breastfeeding. Contact the maternity team or urgent care for fever, infection signs, trouble breathing, severe headache, chest pain, or a sudden serious illness.

Older adults

A sudden illness, cancer, frailty, a recent procedure, or treatment may change the level. Keep the medicine list and the rest of the workup with the result.

People receiving immune or cancer treatment

Cell therapy, steroids, IL-6 receptor blockers, and anti-IL-6 antibodies can change the number. Record the dose and timing. Follow the treating team's plan.

03

How to prepare for an IL-6 blood test

Ask why IL-6 is being ordered and what the result could change. Specialists and hospitals use it for selected questions. It is not a usual first test for brain fog.

Get the laboratory name, order code, sample type, tube, and shipping guide before the draw. Serum and EDTA plasma are different samples. Some methods need quick separation and frozen shipping.

Do not fast unless the written order says to. Several current US IL-6 tests need no special preparation, but another test drawn at the same visit may require fasting.

Note any fever, infection, injury, surgery, vaccine, hard exercise, poor sleep, or inflammatory flare near the draw. Working muscles can release IL-6.

List medicines and infusions. Include tocilizumab, sarilumab, siltuximab, steroids, immune therapy, and recent cancer treatment. These treatments can change the measured level or interfere with the test.

For repeat testing, ask whether to use the same laboratory, method, sample, and time of day. IL-6 can change during the day.

Do not wait for this test if you are very ill. Get urgent care for severe trouble breathing, fainting, confusion, a fast-rising fever, very low blood pressure, or signs that an organ is failing.

01

Save the reason for the test

Write whether the test is part of an infection, inflammatory disease, Castleman disease, cancer-treatment, cytokine-release, severe COVID, or research workup. Brain fog alone does not define the right use.

02

Save the method and specimen

Keep serum or plasma, laboratory, order code, assay, unit, reference interval, collection time, processing time, and temperature with the number.

03

Add same-day context

Note illness, exercise, sleep, treatment, or another change near the draw. This helps you compare the result with an earlier one.

04

Read nearby results

Compare the number with symptoms and the tests chosen for the suspected condition. The surrounding workup usually carries more meaning than this cytokine alone.

05

Define the next decision

Ask what the result changes. It may guide urgent care, follow a planned trend, lead to another test, or add little on its own.

04

How to understand an IL-6 result

Read the laboratory, sample, method, unit, and printed range first. Then add sample handling, illness, exercise, medicines, and the other tests. Do not copy a cutoff from another laboratory.

Within this laboratory's interval

Within the performing laboratory's interval on a usable specimen

This method did not find a high level at that time. Read it with your symptoms and other tests because a normal result does not rule out illness.

Near the limit, changed, or discordant

Near the printed limit, changed from baseline, or discordant with symptoms

Check the method, sample handling, time of day, illness, exercise, and medicines. Compare it only with the same method. Repeat it only when the result could change a decision.

Above this laboratory's interval

Above the laboratory's interval or markedly elevated in an acute-care pathway

The immune system may be active, but the number does not show why. How ill the person is decides the urgency.

A value of 3 pg/mL can be high or in range

Current US upper limits range from 1.8 or 2.0 to 6.4 or 7 pg/mL because the methods differ. None is a universal target or a cutoff for Long COVID or brain inflammation.

See research details

The notes below explain laboratory methods, hospital use, Long COVID studies, exercise, thinking research, and medicine effects.

SourceThere is no universal IL-6 reference limit ContextCurrent US examples differ. A Eurofins-Viracor send-out lists under 1.8 pg/mL from a limited group of apparently healthy adults and says it is not diagnostic. ARUP lists 2.0 pg/mL or less. Mayo lists under 6.4 pg/mL. Labcorp cites 7 pg/mL as the 95th percentile in 817 apparently healthy people.

Use only the interval printed by the performing laboratory. Do not transfer a number from another assay, serum method, or plasma panel.

SourceSpecimen handling is part of the result ContextARUP requires serum separated within two hours and shipped frozen, rejects refrigerated specimens, and uses a multiplex bead assay. Mayo accepts refrigerated serum for 14 days with its immunoenzymatic method. Another laboratory uses frozen EDTA plasma and a Luminex method.

Save the tube, specimen, separation time, transport temperature, and assay. Without the method, you can't safely compare the number with another laboratory's result.

SourceOne hospital cutoff has a narrow job ContextLabcorp describes a 35 pg/mL cutoff studied for later mechanical ventilation in confirmed, symptomatic COVID-19 patients presenting to an emergency department. The validation group had 49 hospitalized patients, 19 of whom were intubated; positive predictive value was 59 percent and negative predictive value 86 percent in that group.

Do not transfer 35 pg/mL to chronic symptoms or outpatient safety decisions. It belongs only to the acute-care population and outcome described above.

SourceLong COVID research is mixed ContextA 2023 meta-analysis reported higher IL-6 in Long COVID, but I-squared was 100 percent for the pooled mean and healthy-control comparison. CDC's March 2026 guidance does not recognize any laboratory marker as diagnostic for the condition.

Use history, examination, symptom-led testing, function, and competing diagnoses. Do not require a high cytokine result for symptoms to be real.

SourceThe newest controlled study found no clear group difference ContextOmdal 2026 compared 48 people with Long COVID and 48 age- and sex-matched recovered controls at a median of 69 weeks. Routine assays showed no inflammatory-marker difference, and nominal ultrasensitive IL-6 differences did not survive correction for multiple comparisons.

This small study does not disprove immune involvement. It shows why one peripheral result cannot be required to confirm a post-COVID illness or a process inside the brain.

SourceA 2026 imaging association is not a diagnosis ContextCao 2026 studied 52 people with Long COVID, 21 recovered people, and 26 healthy controls. In the Long COVID group, larger choroid-plexus volume correlated with higher IL-6, while the group itself had smaller choroid-plexus volume.

The observational finding supports research into blood-CSF barrier biology. It does not let a blood result prove brain inflammation, white-matter injury, or the cause of one person's symptoms.

SourceCognitive outcomes do not track one cytokine consistently ContextCouto 2025 followed 108 adults after moderate or severe COVID-19 at about 6.9 and 23.5 months. The inflammatory indices did not significantly predict later anxiety, post-traumatic stress, or cognition.

Record the actual task failure, timing, sleep, exertion response, mood, medicines, and neurological findings separately from IL-6.

SourceExercise and pathway medicines can change the reading ContextContracting muscle releases IL-6, and Kistner 2024 found duration-related changes during moderate walking. Mayo warns that IL-6 receptor inhibitors can raise measured IL-6 by reducing clearance, while anti-IL-6 antibodies can interfere with measurement.

Record recent exertion and every immune treatment. Do not judge fitness or treatment response from IL-6 alone.

05

What you can do while the result is being reviewed

Food or supplements cannot safely target one IL-6 number. Keep a clear record, recover from illness, and treat any known health problem.

Keep a seven-day context record

For the week around the draw, record temperature, infection signs, sleep, exercise, injury, a procedure or vaccine, any flare, and treatment timing.

Recover from acute illness before measuring a baseline

Rest, drink enough, eat foods you can tolerate, and follow the care plan. Ask when to repeat a baseline after fever, infection, surgery, or hard exercise has passed.

Use movement that fits your condition

Exercise can briefly raise IL-6. If activity causes a delayed crash, pace your effort instead of pushing through.

Work on known sources

Work on health problems you already know about, such as smoking, poor sleep, dental disease, infection, or inflammatory disease. Ask a clinician to review medicine problems.

Choose the test that answers the question

Before paying for another cytokine test, ask what would give a clearer answer. The better next step may be routine blood work, a culture, imaging, a sleep check, a medicine review, or a test for one disease.

What one IL-6 value should not start

Do not start an IL-6 blocker, leftover steroid, long course of anti-inflammatory medicine, supplement stack, detox, fast, or severe diet from one result. Get urgent care for severe trouble breathing, fainting, confusion, or blue or gray lips. Very low blood pressure, a fast-rising fever, or signs that an organ is failing also need urgent care.

06

What to save from an IL-6 report

Keep these together

  • Value, unit, range, laboratory, order code, method, report date, and serum or plasma
  • Draw time, separation time, tube, shipping temperature, handling notes, and any repeat
  • Fever, infection, injury, surgery, vaccine, hard exercise, sleep loss, and any flare that week
  • Tocilizumab, sarilumab, siltuximab, steroids, immune or cancer treatment, and the last dose time
  • Other blood or imaging results, the clinician's reading, action taken, repeat plan, and next decision

Question for the visit

“Does this result change my tests or care? Could the sample, illness, exercise, or treatment explain it? What should happen next?”
07

Sources for Interleukin-6 (IL-6) Blood Test

01
Mayo Clinic Laboratories, Interleukin-6, Serum

Current July 2026 method, under 6.4 pg/mL interval, handling, nonspecific interpretation, and medicine effects.

02
ARUP Laboratories, Interleukin 6, Serum

Current multiplex method, 2.0 pg/mL or less interval, frozen transport, diurnal variation, and research-led use.

03
Labcorp, Interleukin-6, Serum

Current Roche method, 7 pg/mL population limit, specimen rules, and narrow hospitalized COVID-19 study.

04
St. Louis Children's Hospital and Eurofins-Viracor, IL-6

Under 1.8 pg/mL limited-adult interval, no fasting preparation, frozen handling, and non-diagnostic limit.

05
National Jewish Health, IL-6 by Luminex

EDTA plasma method, frozen transport, and the same published male and female interval.

06
Seattle Children's Hospital, Cytokine Panel

Pediatric clinical cytokine-panel method and assay-specific IL-6 interval.

07
Lee et al., pediatric cytokine panels, 2024

Pediatric clinical use, processing, and 150-control assay-specific reference development.

08
CDC, Long COVID Clinical Guidance

Current March 2026 diagnostic boundaries, symptom-led care, function, diaries, and post-exertional malaise.

09
CDC, Diagnosing ME/CFS

No confirmatory biomarker, history and function, child context, and activity-symptom records.

10
CDC, Evaluation of ME/CFS

Current April 2026 differential workup, false-positive risk, and targeted testing.

11
Yin et al., 2023

Post-COVID IL-6 meta-analysis and extreme between-study heterogeneity.

12
Omdal et al., 2026

48-versus-48 matched study with no corrected IL-6 group difference.

13
Cao et al., 2026

Choroid-plexus imaging and IL-6 association in a small observational cohort.

14
Couto et al., 2025

Two-year 108-adult post-COVID cohort and lack of significant inflammatory-index prediction of cognition.

15
Kistner et al., 2024

Duration-related IL-6 response to moderate walking and exercise-context limit.

See each claim's sources

limitation

The 35 pg/mL Elecsys cutoff was studied for respiratory-support risk in a small hospitalized confirmed-COVID population, not outpatient Long COVID or brain fog.

limitation

Current CDC guidance says no laboratory test can diagnose or rule out Long COVID, so IL-6 cannot be used alone for that purpose.

context

A 2023 meta-analysis found higher mean IL-6 in Long COVID but extreme between-study heterogeneity.

context

A 2026 matched study of 48 Long COVID participants and 48 recovered controls found no routine inflammatory-marker difference and no corrected ultrasensitive IL-6 difference.

context

A 2026 imaging study found an IL-6 and choroid-plexus-volume correlation in 52 Long COVID participants, which does not validate individual diagnosis.

context

A 2025 two-year cohort of 108 adults after moderate or severe COVID-19 found that inflammatory indices did not significantly predict later cognition.

context

Contracting muscle releases IL-6, and a 2024 walking study found duration-related IL-6 changes during moderate activity.